Introduction {#sec1-1}
============

Breast cancer is the commonest malignancy among females worldwide and also it is the leading malignancy among females in Asian countries as well (Farley et al., 2015). In Sri Lanka, breast cancer is the commonest cancer since the year 2000, when all age groups and both females and males are taken into account (Cancer Incidence Data, 2005 and 2009). The breast cancer mortality rate has increased and it is the cause of highest cancer mortality rate for Sri Lankan females (Cancer Incidence Data, 2005 and 2009).

There are well established risk factors for breast cancer; family history of breast cancer, early age at menarche, late age at menopause, being \>30 years at first full term pregnancy, nulliparity, lack of breast feeding, use of oral contraceptive pills (OCP) and use of hormone replacement therapy (HRT) (Hulka and Moorman, 2001; De Silva et al., 2010; Lodha et al., 2011).

Presence of these risk factors is associated with clinically important tumour characteristics including poor prognostic features (Lu et al., 2011).

Hence, risk factors of breast cancer may predict the survival of females with breast cancer. However the effect of the risk factors on the survival of patients who have developed breast cancer is still controversial. Late age at first birth, multiparity, recent use of OCP and high BMI (Body mass index) are reported to have a negative impact on the survival of breast cancer patients (Barnett et al., 2008; Alsaker et al., 2013; Butt et al., 2009). Contrastingly some investigators have found that use of OCP and parity had no impact on survival (Barnett et al., 2008; Lu et al., 2011). Many previous publications have described that reproductive or hormonal risk factors had no impact on the survival of patients with breast cancer (Barnett et al., 2008; Ewartz et al., 1991).

Data on risk factors of breast cancer in Sri Lankan female population is sparse and the effect of those risk factors on the survival is not available in the literature. Therefore this study was designed to determine the distribution of breast cancer risk factors among those who have developed breast cancer in the Southern Province of Sri Lanka and to analyze the effect of breast cancer risk factors on the breast cancer specific survival (BCSS) of the cohort.

Materials and Methods {#sec1-2}
=====================

This was a study with retrospective and prospective patient follow-up. Out of the 1068 female patients with breast cancer who had sought the services of the Diagnostic Immunohistochemistry Laboratory, Department of Pathology, Faculty of Medicine, University of Ruhuna, Sri Lanka from May 2006 to December 2012, only 944 patients gave consent to participate in the study. Our unit was the referral center for Immunohistochemistry services in the Southern Province of Sri Lanka during this period. The referrals to our unit came from the single Oncology unit in the Southern Province whichreceives referrals from all hospitals with surgical units in the Southern Province. The study was approved by the Ethical Review Committee of our institution.

Data on risk factors were collected at the first interview with the patient using an interviewer administered questionnaire. All breast cancer patients who were alive were interviewed at the clinic or at their residences. If the patient was dead, by the time of the study was commenced, the closest relative of the dead patient was interviewed to obtain information on risk factors. A few patientswho neither attendedtheclinic nor consented forhome visits, were interviewed over the phone.

The information on potential breast cancer risk factors; family history of breast cancer or ovarian cancer or other types of cancer up to 4th degree and history of benign breast diseases were collected. Menstrual and reproductive history was taken which included age at menarche, age at menopause, menopausal status at the diagnosis of the disease, number of children born alive, age at first live birth and breast feeding practices. Measuring the body weight and calculation of body mass index were not done as the patients were enrolled retrospectively. Pre- and postmenopausal status of the subjects was defined as follows (Butt et al., 2012). The patients who had natural menopause (absence of menstruation for at least six months before the diagnosis of breast cancer) or who had bilateral oophorectomy before the diagnosis of breast cancer or who had hysterectomy alone (without oophorectomy) and were more than 55 years of age at the time of the diagnosis of breast cancer were considered post-menopause. The patients who were still having menstrual cycles or attained menopause during the period of receiving chemotherapy or females who have had a hysterectomy without bilateral oopherectomy and were aged \<55 years at the time of the diagnosis of breast cancer were considered as pre-menopause.

The duration of breast feeding was calculated in months. The total number of months of breastfeeding was calculated as a summation of duration of breast feeding to all live births of a subject (De Silva et al., 2010). A study subject was considered to have exposure to passive smoking if she had a family member who is a smoker living in the same house. The study population was analyzed for the risk factors according to the high and low risk categories defined by Hulka and Moorman (2001) ([Table 1](#T1){ref-type="table"}).

###### 

Risk Factors of Breast Cancer

  Factor                                                                                        High-risk          Low-risk
  --------------------------------------------------------------------------------------------- ------------------ -------------
  Family history of breast cancer                                                               Yes                No
  History of benign breast diseases                                                             Yes                No
  Age at first full-term pregnancy[\#](#t1f2){ref-type="table-fn"}                              \>30 years         \<20 years
  Age at menarche[\#](#t1f2){ref-type="table-fn"}                                               \<12 years         \>14 years
  Age at menopause[\#](#t1f2){ref-type="table-fn"}                                              \>55 years         \<45 years
  Parity[\#](#t1f2){ref-type="table-fn"}                                                        Nulliparous        Multiparous
  Breast feeding[\#](#t1f2){ref-type="table-fn"}                                                None/\<12 months   \>24 months
  Recent use of hormonal contraceptives (OCP)[\*](#t1f1){ref-type="table-fn"}                   Yes                No
  Hormone replacement therapy- recent and long-term use (HRT)[\*](#t1f1){ref-type="table-fn"}   Yes                No
  Alcohol consumption                                                                           Yes                No
  Smoking                                                                                       Active smoking     No

The use OCP or HRT for at least a period of one month within the 10 years before the diagnosis of the disease was considered a risk (Trivers et al., 2007);

The patients who fall within the intermediate group are considered to have a risk comparable to the general population and not included in neither high nor low risk group

Collection of these data was based on patient's recall memory. If they were unable to recall, those data on risk factors were considered as missing/unknown data.

Association of breast cancer risk factors with tumour characteristics {#sec2-1}
---------------------------------------------------------------------

The study subjects were categorized into two groups; patients with a family history of cancer and those who have no family history of cancer. The patients with a family history of cancer were subdivided; patients with a family history of breast cancer and patients with a family history of other malignancies.

The histopathological features were compared between groups of patients as follows;

− family history of cancer versus no family history of cancer− family history of breast cancer versus no family history of cancer− family history of other malignancies versus no family history of cancer

All the study subjects were divided into two groups; premenopausal and postmenopausal, based on their menstrual history. The histopathological features of each of the two groups were compared.

Statistical analysis {#sec2-2}
--------------------

The chi-square test was performed to compare the categorical variables in the different groups. The BCSS was estimated using the Kaplan-Meier model and differences were examined using the log rank test.

The BCSS time was calculated from the date of diagnosis of the disease to the date of death. Patients who died of breast cancer or who died with breast cancer (progression/metastasis) were included (Rakha, 2013). Patients died of other causes or from unknown causes were censored to the date of death. The cause of death of the patient was obtained from the death certificate issued by the Department of Registrar General.

The univariate analysis was performed using Cox proportional hazards model with 95% CI. All covariates which had a p value \<0.100 were to be taken for multivariate analysis. Multivariate analysis was done with Cox proportional hazards model with backward stepwise factor retention method.

All p values \<0.05 were considered statistically significant and all analyses were performed using the SPSS statistical package.

Results {#sec1-3}
=======

A total of 944 breast cancer patients were included in this study. Descriptive data on risk factors are given in the [Table 2](#T2){ref-type="table"}.

###### 

Distribution of Risk Factors among the Study Cohort

  Risk factor                        Frequency n (%)   Risk factor                         Frequency n (%)
  ---------------------------------- ----------------- ----------------------------------- -----------------
  Family history of cancer                             Parity                              
   Breast cancer                     77 (8)             Parous                             794 (84)
   Other cancer                      206 (22)           Nulliparous                        150 (16)
   Both                              32 (3.4)          Number of children                  
   No cancer                         627 (66.6)         \>3                                244 (31)
   Unknown                           2                  03-Jan                             550 (69)
  Age at menarche                                      Breast feeding                      
   Low Risk (\>14 years)             260 (30.7)         Yes                                782 (83)
   Normal (12-14 years)              443 (52.3)         No                                 162 (17)
   High Risk (\<12 years)            144 (17)          Duration of breast feeding          
   Unknown                           97                 \>24 months                        664 (86)
  Menopausal state                                      \<=12 months                       49 (6)
   Premenopausal                     352 (40)           13-24 months                       57 (7)
   Postmenopausal                    538 (60)           Unknown                            12
   Unknown                           54                History of benign breast diseases   
  Age at menopause                                      Presence                           95 (10)
   Low risk (\<45 years)             58 (11)            Absence                            843 (90)
   Normal (45-55 years)              427 (85)           Unknown                            6
   High risk (\>55 years)            21 (4)            Use of OCP                          
   Unknown                           32                 Yes                                114 (12)
  Age at first full term pregnancy                      No                                 814 (88)
   Low risk (\<20 years)             92 (12)            Unknown                            16
   Normal (20-30 years)              433 (55)          Smoking                             
   High risk (\>30 years)            263 (33)           Passive                            333 (35)
   Unknown                           6                  None                               609 (65)

n, number; %, percentage; OCP, oral contraceptive pills

The mean age at menarche of the study population was 13.9 (SD±1.6). The mean age at menarche of high risk, normal and low risk groups were 11.65 (SD±0.7), 13.6 (SD±0.5) and 15.4 (SD±0.9) respectively.

The majority (60%) of the patients were postmenopausal. The mean age of the premenopausal group was years 42.3 years (SD ± 6.3) while it was 59.6 years (SD ± 8.1) in the postmenopausal group. The mean age at menopause was 48.3 years (SD±3.8) for the study population. The mean age at menopause of high risk (\>55 years=4%), normal (45-55years=84%) and low risk (\<45 years=12%) groups were 55.5 (SD±1.1), 48.9 (SD±2.6) and 41.2 (SD±2.6) years respectively. The majority (84%) of the study population was parous and 31% had more than three children.

The mean age at first full term pregnancy was 27 years (SD±6). The mean age of high risk (\>30 years), normal (20-30 years) and low risk (\<20 years) groups were 33.9 years (SD±3.4), 24.7 years (SD±2.9) and 18.2 years (SD±1.1) respectively. The majority of the parous women (70%) had breast fed for more than 24 months and only 1.3% had not breast fed.

The majority of the study population (90 %) had no history of benign breast diseases. Those who had a history of benign breast disease, either had it on the same side as the breast cancer (8%), or in the contra-lateral breast (2%).

A 12% of the total study population had used OCPs and had commenced at different ages before the diagnosis of breast cancer. The use of OCP is considered as a risk factor, if it has been used within the 10 years before the diagnosis of the breast cancer (Trivers et al., 2007). A 4% of the subjects had used OCP within this period and can be considered having had a higher risk.

Only a 35.3% had been exposed to passive smoking and there were no active smokers. There were only two patients who had consumed alcohol out of the total study population. The majority of the patients had at least one risk factor (65.7%). Almost one third of patients did not have a single risk factor of breast cancer.

Association of breast cancer risk factors with tumour characteristics {#sec2-3}
---------------------------------------------------------------------

The tumour characteristics of the study cohort are given in the [Table 3](#T3){ref-type="table"}. There was no statistically significant difference between the patients with and without family history of cancer and, the patients with a family history of other malignancies and patients with no family history of any cancer, with regard to any of the tumour characteristics considered for this study.

###### 

Profile of the Tumour Characteristics of the Study Cohort

  Tumour features               Frequency n (%)   Tumour features     Frequency n (%)
  ----------------------------- ----------------- ------------------- -----------------
  Age at presentation                             Lymph node stage    
   \<=35 years                  64 (7)             Stage 0            404 (45)
   36-60 years                  661 (70)           Stage 1            223 (25)
   \>60 years                   219 (23)           Stage 2            173 (19)
  Presence of associated DCIS                      Stage 3            99 (11)
   Presence                     331 (36)           Unknown            45
   Absence                      599 (64)          TNM stage           
   Unknown                      14                 I                  165 (19)
  Tumour size                                      II                 415 (47)
   \<20mm                       294 (33)           III                286 (32)
   \>20-50mm                    523 (59)           IV                 14 (2)
   \>50mm                       67 (8)            Unknown             64
   Unknown                      60                 Expression of ER   
  Nottingham grade                                 Positive           320 (40)
   Grade 1                      96 (12)            Negative           485 (60)
   Grade 2                      355 (45)           Unknown            139
   Grade 3                      339 (43)          Expression of PR    
   Unknown                      154                Positive           334 (42)
  Lympho-vascular invasion                         Negative           462 (58)
   Presence                     260 (28)           Unknown            \(148\)
   Absence                      667 (72)                              
   Unknown                      17                                    

n, number; %, percentage; DCIS, ductal carcinoma insitu; TNM, tumour-node-metastasis; ER, oestrogen receptor; PR, progesterone receptor

However, there was a statistically significant difference between the patients who had a family history of breast cancer and no family history of any cancer in terms of the presence or absence of lymph node metastasis (p=0.011) and pathological stage of the tumour (p=0.042) ([Table 4](#T4){ref-type="table"}).Patients with a family history of breast cancer had higher prevalence of lymph node metastasis and higher pathological stage compared to the patients without a family history of any cancer.

###### 

Comparison of Histopathological Features between the Patients Having a Family History of Breast Cancer and No Family History of Any Cancer

  Histopathological feature     Family history of breast cancer   No family history of any cancer   p value                   
  ----------------------------- --------------------------------- --------------------------------- ----------- ----- ------- --
  Presence of associated DCIS                                                                                         0.919   
   Yes                          39 (36%)                                                            221 (36%)                 
   No                           68 (64%)                                                            394 (66%)                 
   Unknown data                                                   2                                             12            
  Tumour size                                                                                                         0.786   
   T1 (≤20 mm)                  34 (33%)                                                            205 (35%)                 
   T2 (\>20-≤50 mm)             59 (58%)                                                            346 (58%)                 
   T3 (\>50 mm)                 9 (9%)                                                              41 (7%)                   
   Unknown data                                                   5                                             35            
  Nottingham grade                                                                                                    0.3     
   Grade 1                      14 (14%)                                                            66 (13%)                  
   Grade 2                      49 (51%)                                                            226 (44%)                 
   Grade 3                      34 (35%)                                                            225 (43%)                 
   Unknown data                                                   12                                            110           
  Presence of LVI                                                                                                     0.101   
   Yes                          37 (35%)                                                            166 (27%)                 
   No                           70 (65%)                                                            452 (73%)                 
   Unknown data                                                   2                                             9             
  Lymph-node metastasis                                                                                               0.011   
   Yes                          69 (66%)                                                            315 (53%)                 
   No                           35 (34%)                                                            281 (47%)                 
   Unknown data                                                   3                                             31            
  Lymph-node stage                                                                                                    0.053   
   0                            35 (34%)                                                            281 (47%)                 
   1                            27 (26%)                                                            144 (24%)                 
   2                            26 (25%)                                                            108 (18%)                 
   3                            16 (15%)                                                            63 (11%)                  
   Unknown data                                                   3                                             31            
  Nottingham prognostic index                                                                                         0.217   
   ≤3.4                         9 (10%)                                                             83 (17%)                  
   3.4-5.4                      50 (54%)                                                            253 (51%)                 
   \>5.4                        33 (36%)                                                            155 (32%)                 
   Unknown data                                                   17                                            136           
  Pathological stage                                                                                                  0.042   
   I                            13 (13%)                                                            120 (21%)                 
   II                           44 (43%)                                                            277 (47%)                 
   III                          44 (43%)                                                            176 (30%)                 
   IV                           1 (1%)                                                              12 (2%)                   
   Unknown data                                                   7                                             42            

n, number; p, significance; DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ; LVI, lympho-vascular invasion; unknown data, information was not available

In the present study, majority of premenopausal patients had associated DCIS (p\<0.001) and large tumours (p=0.015) with positive lymph nodes (p=0.016) ([Table 5](#T5){ref-type="table"}) compared to the postmenauposal patients.

###### 

Comparison of Histopathological Features between Pre- and Postmenopausal Breast Cancer Patients

  Histopathological feature     Postmenopausal (n=538)   Premenopausal (n=352)   p value                    
  ----------------------------- ------------------------ ----------------------- ----------- ---- --------- --
  Presence of associated DCIS                                                                     \<0.001   
   Yes                          159 (30%)                                        147 (42%)                  
   No                           370 (70%)                                        200 (58%)                  
   Unknown data                                          9                                   5              
  Tumour size                                                                                     0.015     
   T1 (≤20 mm)                  171 (34%)                                        107 (32%)                  
   T2 (\>20--≤50 mm)            303 (61%)                                        191 (57%)                  
   T3 (\>50 mm)                 27 (5%)                                          36 (11%)                   
   Unknown data                                          37                                  18             
  Nottingham grade                                                                                0.66      
   Grade 1                      58 (13%)                                         33 (11%)                   
   Grade 2                      197 (45%)                                        139 (46%)                  
   Grade 3                      183 (42%)                                        128 (43%)                  
   Unknown data                                          100                                 52             
  Presence of LVI                                                                                 0.1       
   Yes                          128 (24%)                                        103 (29%)                  
   No                           396 (76%)                                        247 (71%)                  
   Unknown data                                          14                                  2              
  Lymph-node metastasis                                                                           0.016     
   Yes                          260 (51%)                                        202 (59%)                  
   No                           250 (49%)                                        138 (41%)                  
   Unknown data                                          28                                  12             
  Lymph-node stage                                                                                0.067     
   0                            250 (49%)                                        138 (41%)                  
   1                            118 (23%)                                        95 (28%)                   
   2                            89 (17%)                                         74 (22%)                   
   3                            52 (10%)                                         32 (9%)                    
   Unknown data                                          29                                  13             
  Nottingham prognostic index                                                                     0.358     
   ≤3.4                         68 (16%)                                         38 (13%)                   
   3.4-5.4                      219 (53%)                                        150 (52%)                  
   \>5.4                        127 (31%)                                        100 (35%)                  
   Unknown data                                          124                                 64             
  Pathological stage                                                                              0.128     
   I                            102 (20%)                                        61 (18%)                   
   II                           240 (48%)                                        157 (47%)                  
   III                          145 (29%)                                        115 (34%)                  
   IV                           11 (2%)                                          2 (1%)                     
   Unknown data                                          40                                  17             

p, significance; DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ; LVI, lympho-vascular invasion; Unknown data, information was not available

###### 

Univariate Analysis of Breast Cancer Risk Factors

  Risk factor                       Five-year BCSS   Log-rank test p value   HR          95% CI          Risk factor                         Five-year BCSS   Log-rank test p value   HR          95% CI
  --------------------------------- ---------------- ----------------------- ----------- --------------- ----------------------------------- ---------------- ----------------------- ----------- ---------------
  Family history of cancer                                                                               Age at first full term pregnancy                                                         
   Presence                         76%              0.204                   1.229       0.894 - 1.690    High risk (\>30 years)             77%              0.124                   0.923       0.549 - 1.552
   Absence                          80%                                      Reference                    Normal (20-30 years)               81%                                      0.666       0.403 - 1.102
  Family history of breast cancer                                                                         Low risk (\<20 years)              78%                                      Reference   
   Presence                         71%              0.139                   1.397       0.895 - 2.182   Parity                                                                                   
   Absence                          80%                                      Reference                    Parous                             79%              0.999                   Reference   
  Family history of other cancers                                                                         Nulliparous                        78%                                      1           0.657 - 1.520
   Presence                         78%              0.495                   1.14        0.782 - 1.662   Parous                                                                                   
   Absence                          80%                                      Reference                    1-3 kids                           79%              0.949                   0.988       0.689 - 1.417
  Degree of relationship                                                                                  \>3 kids                           77%                                      Reference   
   1st degree                       76%              0.94                    1.311       0.534 - 3.220   Breast feeding                                                                           
   2nd degree                       77%                                      1.309       0.522 - 3.284    Yes                                80%              0.76                    Reference   
   3rd degree                       77%                                      1.316       0.494 - 3.506    No                                 79%                                      1.06        0.729 - 1.541
   4th degree                       77%                                      Reference                   Duration of breast fed                                                                   
  Age at menarche                                                                                         ≤12 months                         85%              0.592                   Reference   
   High Risk (\<12 years)           82%              0.339                   1.381       0.786 - 2.425    13-24 months                       71%                                      1.472       0.580 - 3.740
   Normal (12-14 years)             86%                                      0.954       0.594 - 1.531    \>24 months                        81%                                      1.095       0.509 - 2.355
   Low Risk (\>14 years)            87%                                      Reference                   History of benign breast diseases                                                        
                                                                                                          Yes                                80%              0.563                   0.834       0.450 - 1.546
  Menopausal state                                                                                        No                                 79%                                      Reference   
   Premenopausal                    82%              0.762                   Reference                   Use of OCP                                                                               
   Postmenopausal                   82%                                      1.057       0.738 - 1.514    Yes                                87%              0.126                   0.651       0.375 - 1.132
  Age at menopause                                                                                        No                                 79%                                      Reference   
   High risk (\>55 years)           80%              0.674                   1.47        0.367 - 5.878   Smoking                                                                                  
   Normal (45-55 years)             83%                                      1.46        0.629 - 3.392    Passive                            81%              0.475                   0.888       0.640 - 1.231
   Low risk (\<45 years)            91%                                      Reference                    None                               77%                                      Reference   

BCSS, breast cancer specific survival; p, significance; HR, hazard ratio; CI, confidence interval; OCP, oral contraceptive pills

Depending on the status of ER and PR, patients were categorized into three groups; ER or PR positive, ER and PR positive, and ER and PR negative. The prevalence of hormone related risk factors within the above three sub groups was compared. There was no statistically significant association between the hormone receptor subtypes and the hormone related risk factors among thestudysubjects.

The effect of breast cancer risk factors on the BCSS {#sec2-4}
----------------------------------------------------

The five year BCSS of the study cohort was 78.8%. The impact of breast cancer risk factors on the BCSS was analyzed using Cox proportional hazards model. The number of patients presented with a history of HRT (n=14) and alcohol consumption (n=2) were minimal. Therefore, these factors were not considered in the univariate analysis. Five year BCSS rates for subgroups of risk factors and the results of the univariate analysis with hazards ratio for the risk factors are given in the [Table 5](#T5){ref-type="table"}.

Patients with a family history of any cancer or breast cancer or other malignancies, earlier age at menarche, late age at menopause and late age at first full term pregnancy had poor survival compared to the other relevant subgroups of patients with a particular risk factor. The fourth degree relationship of the family history had a better survival compared to the first, second and third degrees of relationship. The patients who had a history of benign breast diseases, ever use of OCPand exposure to passive smoking had an improved prognosis. However, the effect of the use of OCP within the 10 years before the diagnosis was not further analyzed as thenumber ofsuch patients was smaller.

There was no survival difference between parous and nulliparous and premenopausal and postmenopausal groups of patients. Number of children did not influence the survival of the breast cancer patients. Breastfed and never breastfed patients had a similar survival pattern.

Even though there were survival differences between the subgroups of patients with some risk factors, the differences between the survival curves of noneofthe aforesaid breast cancer risk factors were statistically significant. The analysis was repeated amalgamating low risk and no risk categories together against the high risk categories which yet did not reveal any effect on the BCSS. Multivariate analysis was not done as no risk factor was found to have a statistically significant effect on the survival in the univariate analysis.

Although the subset of patients with family history of breast cancer had poor prognostic tumour characteristics compared to the patients without a family history of any cancer, no survival difference was identified between the two groups (p=0.139). The subset of postmenopausal patients too had no survival advantage over the premenopausal patients contrary to the observed significant difference in the prevalence of some good prognostic features among the postmenopausal patients.

Discussion {#sec1-4}
==========

The aim of this study was to determine the prevalence of established breast cancer risk factors among those who have developed breast cancer and its impact on/or association with the BCSS of females with breast cancer in the Southern Province of Sri Lanka. The results of this study revealed that one third of the breast cancer patients did not have a single risk factor although they had a breast cancer.In the present study, the majority of the patients; did not have a family history of cancer; were parous; had breast fed; had not attained menarche at an early age; did not have late menopause; did not have a late first full term pregnancy; had not used OCP within the 10 years before the diagnosis of the breast cancer; had not used HRT, alcohol and not exposed to active or passive smoking.

Epidemiological studies conducted on different populations have identified different combinations of well-established risk factors to be more significant for the development of breast cancer in their populations. Most of these studies were case-controls and there are very few studies done on cases of breast cancer alone, in the literature.

There is only one case-control study done on breast cancer to find out the risk factors for breast cancer in Sri Lanka. They found that lack of breastfeeding, having a family history of breast cancer, being postmenopausal, having had a previous abortion and exposure to passive smoking are significant risk factors for breast cancer while age at menarche, BMI, age at first full term pregnancy, use of OCP for more than five years are not significant risk factors in the Sri Lankan population (De Silva et al., 2010). Information on previous abortions and BMI were not collected for the present study. The majority of the patients in the present study did not have aforesaid risk factors except being a postmenopausal female (57%). However, the prevalence of the following risk factors; nulliparity, late age at first full term pregnancy and passive smoking were higher among the present study population while early age at menarche, family history of breast cancer and lack of breastfeeding were lower than in the study done by De Silva and colleagues (2010).

In the present study, patients with a family history of breast cancer was less prevalent compared to the Western countries and similar to the other Asian countries (Leong et al., 2010). First degree relative with a breast cancer is one of the recognized risk factors for breast cancer (Hulka and Moorman, 2001). Later, it was found that family history is a prognostic factor rather than a simple risk factor for breast cancer patients (Atri et al., 2002). Presence of family history indicates inheritance of genetic alterations that modify the risk of developing breast cancer (Cipollini et al., 2004). Therefore females with breast cancer may carry different genetic alterations which may affect the tumour characteristics. The present study demonstrated that family history of breast cancer was associated with a higher prevalence of lymph node metastasis and advanced pathological stage. Similar to the present study, some investigators have found that patients with a family history of breast cancer had a high prevalence of lymph node involvement (Tazzite et al., 2013).

In the present study cohort, the difference in the tumour characteristics has not made any significant effect on the survival of patients with family history of breast cancer. Therefore patients presented with a family history of breast cancer did not have a significant difference in the BCSS compared to the patients with no family history of cancer.Previous studies that compared the survival between breast cancer cases with and without family history reported inconsistent results (Thalib et al., 2004; Cao et al., 2011). The recent most publication on this subject tallies well with our study and it has been concluded stating that family history per se is not an independent prognostic feature for recurrence and death in breast cancer patients (Eccles et al., 2015).

Family history of other malignancies had no significant association with the histopathological features of breast cancer in the current study. Although many researchers have found an association between histopathological factors and family history of breast cancer (Molino et al., 2004; Tazzite, et al., 2013), only a few studies have commented on the relationship between histopathological factors and family history of other malignancies (Atri et al., 2002). Atri and colleagues (Atri et al., 2002) foundthat patients with a family history of other malignancies have a significant association with tumour grade and lymphatic invasion, but the present study did not demonstrate any such relationship.

Being a postmenopausal woman is a significant risk factor for developing a breast cancer (De Silva et al., 2010). In the present study, majority of the study subjects were postmenopausal. Menopausal status is an important factor considered in deciding on a specific endocrine treatment plan for hormone sensitive breast cancer patients (De vos et al., 2012). However there were hardly any reports on the association of histopathological tumour characteristics and menopausal status. There are reports to indicate that breast cancers in postmenopausal women are generally better differentiated (Zavango et al., 2000).

In the present study, premenopausal patients had larger tumours with associated DCIS and metastatic lymph nodes compared to the postmenopausal patients. In contrast, Zavango and colleagues, (2000) have found that the premenopausal patients had smaller tumours compared to the postmenopausal and had no difference in axillary lymph node status. The discrepancies of these findings could be due to the mean age of the sample in these studies. In the present study; the mean age of the premenopausal group was less compared to the study done by Zavango and colleagues, (2000).

Even though several parameters were significantly different between the pre- and postmenopausal women, menopausal status did not influence the BCSS in the present study. Menopausal status is an age dependent factor (Zavango et al., 2000). Therefore the age may be confounding the effect of menopausal status on the BCSS. It has been identified that age has a qualitative interaction conferring benefit for one subgroup and harm another. Epidemiologic studies have shown that breast cancer demonstrates age specific heterogeneity that transcends a simple or single cut point such as menopausal status (Anderson, Jatoi and Sherman, 2009).

Hormone related risk factors which include early age at menarche, late age at menopause, late age at first full term pregnancy and nulliparity increase the duration of exposure to oestrogen hormone during the life time of a female. Therefore the patients with those risk factors have a higher risk of developing a breast cancer compared to the others. However, the majority of the study population did not have menarche at an early age and menopause or first full term pregnancy at a late age. The prevalence of early age at menarche in our cohort was less compared to the others (Lodha et al., 2011; Lee at el., 2014). Nulliparity was more prevalent in our study population compared to the Indian and Chinese breast cancer patients (Lodha et al., 2011; Lee at el., 2014).

Many recent studies have demonstrated significant associations between hormone related risk factors of breast cancer and IHC subgroups defined by ER and PR status. Hormone related risk factors were found to be associated with ER/PR positive breast cancers (Setiawan et al., 2009; Yang et al., 2011). Multiparity and lack of breast feeding are also associated with ER/PR negative breast cancers (Work et al., 2014). However, previous studies have reported contradictory findings in terms of association between hormone related risk factors of breast cancer and IHC subgroups (Setiawan et al., 2009; Bao et al., 2011; Turkoz et al., 2012). The results of the present study did not demonstrate a significant association between the hormone related risk factors and the ER/PR status of the breast cancer.

Most previous studies have failed to demonstrate an effect of age at menarche, age at menopause and menopausal status on the survival of breast cancer patients similar to the current study (Barnett et al., 2008; Orgéas et al., 2008; Song et al., 2015). Similar to many published reports, the current study revealed that survival was similar in parous and nulliparous females (Barnett et al., 2008). Some previous studies have found that survival was poor with multiparity and higher age at first birth (Barnett et al., 2008; Alsaker et al., 2013). Contrastingly the prognosis was not influenced by the number of children and late age at first full term pregnancy in the present study. The inconsistency in results may be due to the lack of uniformity in the parameters used and differences in the ethnicity among the individual studies.

Prolonged breastfeeding is a protective factor against development of breast cancer and if the female has not breastfed it becomes a risk factor (De Silva et al., 2010). A high prevalence of this protective factor is observed in our cohort of breast cancer patients too. It is on par with data from the Asian countries and deviates from the Western countries (Lodha et al., 2011; Butt et al., 2012; Lee at el., 2014). In this study population 70% of patients had breast fed for more than 24 months and carried a protective factor. However, breastfeeding has not influenced the survival of breast cancer patients. This finding is consistent with other reports (Trivers et al., 2007; Song et al., 2015).

A history of benign breast disease is a risk for developing a breast cancer (Hulka and Moorman, 2001; Dorjgochoo et al., 2008). The present study population had a lower prevalence of history of benign breast diseases compared to the Shanghai breast cancer study (Dorjgochoo et al., 2008). There was no significant difference between the BCSS of patients with and without history of benign breast cancers.

The exogenous hormones like hormonal contraceptives (eg: use of OCP) and HRT are breast cancer risk factors (De Silva et al., 2010; Hadjisavva et al., 2010). The majority of the study subjects had never used OCP. Only a few of the study subjects, who had used, had been on OCP within the 10 years before the diagnosis of the disease. The prevalence of ever use of OCP was compared with other populations. It was similar to other Asian countries, but less than the non-Asian countries (Barnett et al., 2008; Lodha et al., 2011). Only 1.5% of breast cancer patients in this study had used HRT and the frequency of patients who had used HRT is very much lower than the previous publications (Barnett et al., 2008; Hadjisavvas et al., 2010). Low prevalence of use of HRT may be related to the cultural factors.

Even though some previous reports have stated that the use of OCP had no impact, some investigators have found that recent users of OCP had a higher risk of death compared with non-users (Trivers et al., 2007; Barnett et al., 2008; Lu et al., 2011). Furthermore an earlier study has found a significant trend of decreasing risk of death with increasing time since last use of OCP (Reeves et al., 2007). In this study population, majority of the patients who had used OCP, have used it within/more than 10 years before the diagnosis of the disease. Although our study revealed that patients who had ever used OCP had better survival compared to the others (HR, 0.65; 95% CI, 0.375-1.132), there was no statistical significance (p=0.12) between the two groups.

Alcohol consumption is very rare among Sri Lankan females due to the cultural and spiritual beliefs. Although there were no active smokers, exposure to passive smoking was prevalent in our study cohort. Exposure to passive smoking is a significant risk factor for breast cancer in Asian population (De Silva et al., 2010; Gao et al., 2013; Wada et al., 2015). An improved prognosis with passive smoking was noted which is contradictory to the previous publications (Sajiv et al., 2007). This association did not have any statistical significance. The present study did not collect data on the number of cigarettes used per day at home and hours of exposure to passive smoking which limited the further assessment of the observation. It is possible that the apparent relationship was due to mere chance.

As described above, except for parity all the other risk factors had an impact on the BCSS, none of which were statistically significant. A similar finding has been brought up by Ewertz and colleagues in 1991. Later, researchers have developed studies considering one or two risk factors at a time and found out some impact of them on the survival of breast cancer patients. They have obtained inconsistent results on the association between survival and risk factors as mentioned earlier.

Since this is a retrospective study weight of the patient at presentation was not available. Therefore BMI was not calculated and could not be considered in the study. Information on all risk factors was gathered based on recall memory of the patient. Older patients may not have given the exact age at menarche as they were too old memory to recall. Information on the risk factors of the patients who were already dead by the time of data collection was not available. These limiting factors may have affected the final results of some risk factors.

The prevalence of risk factors among the cohort of breast cancer patients included in this study is less compared to the West. Only a two third of patients had at least one risk factor. A significant proportion of them have protective factors as well; deviating from the global pattern. The results of the present study highlight the need to investigate on factors other than the major established risk factors on the development of breast cancer in Sri Lankan women.

Out of all breast cancer risk factors considered for the study only the family history of breast cancer and premenopausal status were associated with poor prognostic features. Being in line with the other breast cancer risk factors, family history of breast cancer and premenopausal status had no significant effect on the BCSS of patients in the Southern Sri Lanka.
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